Combination Therapy and New Types of Agents for Pulmonary Arterial Hypertension
- 31 March 2007
- journal article
- review article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 28 (1) , 169-185
- https://doi.org/10.1016/j.ccm.2006.11.011
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Simvastatin enhances bone morphogenetic protein receptor type II expressionBiochemical and Biophysical Research Communications, 2006
- Efficacy and Safety of Sildenafil Added to Treprostinil in Pulmonary HypertensionThe American Journal of Cardiology, 2005
- Allelic variation in the serotonin transporter (5HTT) gene contributes to idiopathic pulmonary hypertension in childrenBiochemical and Biophysical Research Communications, 2005
- Survival with first-line bosentan in patients with primary pulmonary hypertensionEuropean Respiratory Journal, 2005
- Adrenomedullin in the treatment of pulmonary hypertensionPeptides, 2004
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary HypertensionCirculation Research, 2004
- Targeted therapy in combination with gemcitabine in non-small cell lung cancerSeminars in Oncology, 2003
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- Increased plasma levels of adrenomedullin in patients with pulmonary hypertensionClinical Science, 1999